Showing 2 results for Opportunities
Many businesses and academic researchers wishing to pursue cutting-edge research ideas with government support lack the resources to navigate the burdensome paperwork requirements required to win federal grants or contracts. DARPA’s Biological Technologies Office (BTO) has created a simplified proposal process to attract and fund new ideas from just those types of innovators—those operating at the intersection of biology and technology who may never have worked with the Defense Department and may otherwise have remained too daunted to try.
Human physiology is a limiting factor in the operational readiness of the
United States Department of Defense. When the human body is damaged or a
physiological system is not functioning optimally, interventions are
required to help mend the injury or support continued performance. DARPA
seeks to develop new technological approaches in medicinal chemistry and
systems pharmacology to expand the druggable proteome and discover new
therapeutic tools in the areas of soft tissue pain/inflammation and
metabolic stress that limit optimal physiological function.. This new
platform technology will directly address needs within the Department of
Defense to support the unique physiological demands of the warfighter and
provide proof-of-concept for novel drug discovery and development pipelines.